SlideShare a Scribd company logo
1 of 4
Find Industry reports, Company profiles
ReportLinker                                                                      and Market Statistics
                                             >> Get this Report Now by email!



Biomaterials China News 1204 - Annual Subscription
Published on April 2012

                                                                                                            Report Summary

BDO capacity will increase rapidly in China due to its strong demand from domestic downstream products,the industry policy support,
and the application of its mainstream production technology.                                              Domestic major PLA
producers are actively expanding their capacity.
China formally released the "Twelfth Five-Year Plan for New Materials Industry" on February 22nd, 2012.
Hunan Xiangwei plans to launch two PVA production lines in March 2012.                                             Shandong Guangyin
officially launches three new long carbon chain nylon production lines in February 2012.
Zhongshan Jiuhe has finished its starch-based biomaterials trial production in February 2012.
Xinfu Pharmaceutical suspended its investment in PBS downstream products due to huge business loss in 2011.
Kingfa smoothly completed a public offering on February 14th, 2012.
Domestic caoutchouc price continues to rise in 2012due to the droughty weather in Yunnan and the rising crude oil price.
Chinese Ministry of Commerce has made an investigation on final review of anti-dumping measures on potato starch from the EU
since February 6th, 2012.
Due to the situation of oversupply, domestic price of cotton may decrease in 2012.
HIT has made a breakthrough in L-lactic acid industrialization by February 2012.
China's PLA export volume and import volume reached 9 tonnes and 467 tonnes respectively in January 2012.
China imported 504,466 tonnes of cassava in January 2012.


China announces to cut its GDP growth target to 7.5% in 2012, according to Premier Wen Jiabao's announcement in his government
work report delivered to the National People's Congress on March 5th, 2012. This is the first time for the Chinese government to lower
its economic growth target after its years-long efforts to maintain an 8% economic growth rate for seven consecutive years. The major
reason of cutting GDP growth target is that the Chinese government plans to focus on accelerating the transformation of the pattern of
economic development and making economic development more sustainable and efficient so as to achieve higher-level
and higher-quality development over a longer period of time.


Meanwhile, the Chinese government has been releasing a series of "Twelfth Five-Year Plan", such as the "Twelfth Five-Year Plan for
New Materials Industry", the "Plan for Grain Processing Industry (2011-2020)", the "Twelfth Five-Year Plan for Industrial Technology
Innovation (2011-2015)", the "Twelfth Five-Year Implementation Plan for Multiple Utilization of Crop Stalk", the "Twelfth Five-Year
Plan for Clean Production", etc. Based on the above policies, as one of strategic emerging industries, biomaterial industry will
undoubtedly enter a stage of rapid development.




                                                                                                             Table of Content

Indian erratic policy to have limited influence on Chinese cotton market


Shanghai Lyocell Fiber gained ecological certification
Yibin Hmei continues promoting silkworm chrysalis protein fiber
Hayley Ann meets its peak period
Jiangsu Xinmin being optimistic on PBST prospect



Biomaterials China News 1204 - Annual Subscription (From Slideshare)                                                               Page 1/4
Find Industry reports, Company profiles
ReportLinker                                                                      and Market Statistics
                                             >> Get this Report Now by email!

Wuhan Huali to expand its capacity
China Hi-tech Group to increase investment in cellulosic fiber


Latest development of lignin in China
Corn price keeps increasing
Inner Mongolia to sharply reduce potato planting area


Trade analysis of PLA in China
Trade analysis of cassava in China
Trade analysis of castor oil and its fractions in China
Shijiazhuang Changshan successfully finishes a bond issue
Asia Cassava Resources to suffer profit reduction
Yunnan Province to suffer sugar cane yield reduction
CHINAPLAS to be held in April 18-21, 2012
Baiyi Industrial to expand its capacity in 2012


Companies mentioned
India Directorate General of Foreign Trade (DGFT) published a ban on cotton export on March 5, 2012, and then it was canceled on
March 12, 2012, which has limited influence on Chinese cotton market.
On March 13, 2012, Shanghai Lyocell Fiber received ecological certification from Switzerland Validation Test Textile.
Yibin Hmei is making efforts to promoting its silkworm chrysalis protein fiber in domestic market.
Hayley Ann is growing fast currently, which may gain great success.
Jiangsu Xinmin is actively accelerating R&D of PBST
On March 29, 2012, Wuhan Huali starts to construct its new research & production base in Wuhan City, Hubei Province, and their
capacity will expand to 100,000t/a in the next two years from 40,000t/a.
China Hi-tech Group will take more measures to support Bao Ding Swan to accelerate cellulosic fiber industrialization.
More and more domestic companies are investing in lignin production and domestic lignin product types are becoming diversified.
Corn price has kept increasing from November 2011, due to its loss of supply and demand balance in domestic market in the short
period.
Inner Mongolia Autonomous Region planned to reduce by above 20% of potato planting area in 2012.
China's PLA export volume and import volume reached 36 tonnes and 684 tonnes respectively in February 2012.
China's import volume of fresh cassava and dry cassava reached 38,166 tonnes and 617,188 tonnes respectively in February 2012.
China's import volume of castor oil and its fractions reached 16,104 tonnes in February 2012.




Biomaterials China News 1204 - Annual Subscription (From Slideshare)                                                      Page 2/4
Find Industry reports, Company profiles
ReportLinker                                                                              and Market Statistics
                                             >> Get this Report Now by email!
              Fax Order Form
              To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                           Europe, Middle East and Africa : + 33 4 37 37 15 56
                           Asia, Oceania and America : + 1 (805) 617 17 93
              If you have any questions please visit http://www.reportlinker.com/notify/contact


              Order Information
              Please verify that the product information is correct and select the format(s) you require.

                    Biomaterials China News 1204 - Annual Subscription




              Product Formats
              Please select the product formats and the quantity you require.

                                     1 User License--USD 2 511.00                Quantity: _____



                                     Corporate License--USD 6 278.00             Quantity: _____




              Contact Information
              Please enter all the information below in BLOCK CAPITALS


              Title:                   Mr                       Mrs    Dr                  Miss             Ms                 Prof

              First Name:                   _____________________________ Last Name: __________________________________

              Email Address:              __________________________________________________________________________

              Job Title:                   __________________________________________________________________________

              Organization:                __________________________________________________________________________

              Address:                     __________________________________________________________________________

              City:                        __________________________________________________________________________

              Postal / Zip Code:            __________________________________________________________________________

              Country:                     __________________________________________________________________________

              Phone Number:                __________________________________________________________________________

              Fax Number:                 __________________________________________________________________________




Biomaterials China News 1204 - Annual Subscription (From Slideshare)                                                                  Page 3/4
Find Industry reports, Company profiles
ReportLinker                                                                                       and Market Statistics
                                             >> Get this Report Now by email!
              Payment Information
              Please indicate the payment method, you would like to use by selecting the appropriate box.




                     Payment by credit card                       Card Number: ______________________________________________


                                                                  Expiry Date     __________ / _________


                                                                  CVV Number _____________________


                                                                  Card Type (ex: Visa, Amex…) _________________________________




                     Payment by wire transfer                     Crédit Mutuel
                                                                  RIB : 10278 07314 00020257701 89
                                                                  BIC : CMCIFR2A
                                                                  IBAN : FR76 1027 8073 1400 0202 5770 189




                      Payment by check                            UBIQUICK SAS
                                                                  16 rue Grenette – 69002 LYON, FRANCE




                                  Customer signature:

                                   




              Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
              http://www.reportlinker.com/index/terms




                                                                       Please fax this form to:

                                                       Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                         Asia, Oceania and America : + 1 (805) 617 17 93




Biomaterials China News 1204 - Annual Subscription (From Slideshare)                                                              Page 4/4

More Related Content

More from ReportLinker.com

Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy ReportReportLinker.com
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013ReportLinker.com
 

More from ReportLinker.com (20)

 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 
World Biomass Report
World Biomass ReportWorld Biomass Report
World Biomass Report
 
World Biofuels Report
World Biofuels ReportWorld Biofuels Report
World Biofuels Report
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy Report
 
Solar PV Report
Solar PV ReportSolar PV Report
Solar PV Report
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
 

Biomaterials China News 1204 - Annual Subscription

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Biomaterials China News 1204 - Annual Subscription Published on April 2012 Report Summary BDO capacity will increase rapidly in China due to its strong demand from domestic downstream products,the industry policy support, and the application of its mainstream production technology. Domestic major PLA producers are actively expanding their capacity. China formally released the "Twelfth Five-Year Plan for New Materials Industry" on February 22nd, 2012. Hunan Xiangwei plans to launch two PVA production lines in March 2012. Shandong Guangyin officially launches three new long carbon chain nylon production lines in February 2012. Zhongshan Jiuhe has finished its starch-based biomaterials trial production in February 2012. Xinfu Pharmaceutical suspended its investment in PBS downstream products due to huge business loss in 2011. Kingfa smoothly completed a public offering on February 14th, 2012. Domestic caoutchouc price continues to rise in 2012due to the droughty weather in Yunnan and the rising crude oil price. Chinese Ministry of Commerce has made an investigation on final review of anti-dumping measures on potato starch from the EU since February 6th, 2012. Due to the situation of oversupply, domestic price of cotton may decrease in 2012. HIT has made a breakthrough in L-lactic acid industrialization by February 2012. China's PLA export volume and import volume reached 9 tonnes and 467 tonnes respectively in January 2012. China imported 504,466 tonnes of cassava in January 2012. China announces to cut its GDP growth target to 7.5% in 2012, according to Premier Wen Jiabao's announcement in his government work report delivered to the National People's Congress on March 5th, 2012. This is the first time for the Chinese government to lower its economic growth target after its years-long efforts to maintain an 8% economic growth rate for seven consecutive years. The major reason of cutting GDP growth target is that the Chinese government plans to focus on accelerating the transformation of the pattern of economic development and making economic development more sustainable and efficient so as to achieve higher-level and higher-quality development over a longer period of time. Meanwhile, the Chinese government has been releasing a series of "Twelfth Five-Year Plan", such as the "Twelfth Five-Year Plan for New Materials Industry", the "Plan for Grain Processing Industry (2011-2020)", the "Twelfth Five-Year Plan for Industrial Technology Innovation (2011-2015)", the "Twelfth Five-Year Implementation Plan for Multiple Utilization of Crop Stalk", the "Twelfth Five-Year Plan for Clean Production", etc. Based on the above policies, as one of strategic emerging industries, biomaterial industry will undoubtedly enter a stage of rapid development. Table of Content Indian erratic policy to have limited influence on Chinese cotton market Shanghai Lyocell Fiber gained ecological certification Yibin Hmei continues promoting silkworm chrysalis protein fiber Hayley Ann meets its peak period Jiangsu Xinmin being optimistic on PBST prospect Biomaterials China News 1204 - Annual Subscription (From Slideshare) Page 1/4
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Wuhan Huali to expand its capacity China Hi-tech Group to increase investment in cellulosic fiber Latest development of lignin in China Corn price keeps increasing Inner Mongolia to sharply reduce potato planting area Trade analysis of PLA in China Trade analysis of cassava in China Trade analysis of castor oil and its fractions in China Shijiazhuang Changshan successfully finishes a bond issue Asia Cassava Resources to suffer profit reduction Yunnan Province to suffer sugar cane yield reduction CHINAPLAS to be held in April 18-21, 2012 Baiyi Industrial to expand its capacity in 2012 Companies mentioned India Directorate General of Foreign Trade (DGFT) published a ban on cotton export on March 5, 2012, and then it was canceled on March 12, 2012, which has limited influence on Chinese cotton market. On March 13, 2012, Shanghai Lyocell Fiber received ecological certification from Switzerland Validation Test Textile. Yibin Hmei is making efforts to promoting its silkworm chrysalis protein fiber in domestic market. Hayley Ann is growing fast currently, which may gain great success. Jiangsu Xinmin is actively accelerating R&D of PBST On March 29, 2012, Wuhan Huali starts to construct its new research & production base in Wuhan City, Hubei Province, and their capacity will expand to 100,000t/a in the next two years from 40,000t/a. China Hi-tech Group will take more measures to support Bao Ding Swan to accelerate cellulosic fiber industrialization. More and more domestic companies are investing in lignin production and domestic lignin product types are becoming diversified. Corn price has kept increasing from November 2011, due to its loss of supply and demand balance in domestic market in the short period. Inner Mongolia Autonomous Region planned to reduce by above 20% of potato planting area in 2012. China's PLA export volume and import volume reached 36 tonnes and 684 tonnes respectively in February 2012. China's import volume of fresh cassava and dry cassava reached 38,166 tonnes and 617,188 tonnes respectively in February 2012. China's import volume of castor oil and its fractions reached 16,104 tonnes in February 2012. Biomaterials China News 1204 - Annual Subscription (From Slideshare) Page 2/4
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Biomaterials China News 1204 - Annual Subscription Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 511.00 Quantity: _____ Corporate License--USD 6 278.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Biomaterials China News 1204 - Annual Subscription (From Slideshare) Page 3/4
  • 4. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Biomaterials China News 1204 - Annual Subscription (From Slideshare) Page 4/4